Effective Management for Acute and Chronic Pain with....

28. US Department of Health and Human Services. FDA blueprint for prescriber education for extended-release and long-acting opioid analgesics. 2017. 29. Substance Abuse and Mental Health Services Administration. 2022 national survey on drug use and health. 2022 NDSUH detailed tables. Table 1.110A. 2023. 30. Stimulant overdose. (2024, November 7). Overdose Prevention. https://www.cdc.gov/overdose-prevention/about/stimulant-overdose.html 31. 31. Brandow AM, Carroll CP, Creary S, Edwards-Elliot R, Glassberg J, Hurley RW, Kutlar A, Seisa M, Stinson J, Strouse JJ, Yusuf F, Zempsky W, Lang E. American Society of Hematology 2020 guidelines for sickle cell disease management of acute and chronic pain. Blood Adv 2020;48:241-248. 32. Carroll CP. Opioid treatment for acute and chronic pain in patients with sickle cell disease. Neurosci Lett 2020, Jan 1;714:134534. doi: 10.1016/j.neulet 33. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2017 National Survey on Drug Use and Health. 2018. HHS Publication No SMA 18-5068, NSDUH Series H-53 34. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2023 National Survey on Drug Use and Health. 35. Fleming MF, Balousek SL, Klessig CL, Mundt MP, Brown DD. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain 2007;8(7):573-582. 36. Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health. Ann Int Med 2017;167(5):293-301. 37. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR Recomm Rep. 2016;65(1):1-49. 38. Lee TH. Zero pain is not the goal. Jama. 2016;315(15):1575-1577. 39. Brummett CM, Waljee JF, Goesling J, et al. New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg. 2017;152(6):e170504. 40. Calcaterra SL, Yamashita TE, Min SJ, Keniston A, Frank JW, Binswanger IA. Opioid prescribing at hospital discharge contributes to chronic opioid use. Journal of general internal medicine. 2016;31(5):478-485. 41. Bateman BT, Franklin JM, Bykov K, et al. Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naive women. Am J Obstet Gynecol. 2016;215(3):353 e351-353 e318. 42. Johnson SP, Chung KC, Zhong L, et al. Risk of prolonged opioid use among opioid-naive patients following common hand surgery procedures. The Journal of hand surgery. 2016;41(10):947-957 e943. 43. Ltd, R. a. M. (n.d.). U.S. Outpatient Surgical Procedures Market by Surgical Procedure Type, Patient Care Setting - US Forecast to 2023. Research and Markets Ltd 2024. https://www.researchandmarkets.com/reports/4746620/us-outpatient-surgical-procedures-market- by?srsltid=AfmBOorDcHf7MPg3_gN_ZjbWsEQc5cHcW1hXGco5xpZiv842F0jbb0lG 44. American Pain Society. Management of acute pain and chronic noncancer pain. Accessed Oct 29, 2018. http://americanpainsociety.org/ education/enduring-materials 45. Frogner BK, Harwood K, Andrilla CHA, Schwartz M, Pines JM. Physical therapy as the first point of care to treat low back pain: An instrumental variables approach to estimate impact on opioid prescription, healthcare utilization, and costs. Health Serv Res 2018;53(6):4629-4646. 46. Centers for Disease Control & Prevention. 2018. Module 2: Treating pain without opioids. Course number WB2859. https://www.cdc. gov/drugoverdose/training/nonopioid 47. Goodman CW, Brett AS. Gabapentin and pregabalin for pain: Is increased prescribing a cause for concern? N Engl J Med 2017;377(5):411- 414. 48. Mathieson S, Maher CG, McLachlan AJ, et al. Trial of pregabalin for acute and chronic sciatica. N Engl J Med 2017;376(12):1111-1120. 49. Blendon RJ, Benson JM. The public and the opioid-abuse epidemic. N Engl J Med 2018;378(5):407-411. 50. Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain 2015;156(4):569-576. 51. Wu CL, Raja SN. Treatment of acute postoperative pain. Lancet 2011;377(9784):2215-2225. 52. Chang AK, Bijur PE, Esses D, Barnaby DP, Baer J. Effect of a single dose of oral opioid and nonopioid analgesics on acute extremity pain in the emergency department: A randomized clinical trial. JAMA 2017;318(17):1661-1667. 53. Poonai N, Datoo N, Ali S, et al. Oral morphine versus ibuprofen administered at home for postoperative orthopedic pain in children: A randomized controlled trial. CMAJ 2017;189(40):E1252-E1258. 54. Solomon DH, Rassen JA, Glynn RJ, Lee J, Levin R, Schneeweiss S. The comparative safety of analgesics in older adults with arthritis. Arch Int Med 2010;170(22):1968-1976. 55. Gil JA, Gunaseelan V, DeFroda SF, Brummett CM, Bedi A, Waljee JF. Risk of prolonged opioid use among opioid-naive patients after common shoulder arthroscopy procedures. Am J Sports Med 2019;47(5):1043-1050.

Powered by